Vascular Biology in Clinical Practice TM Vol. 7, No. 2
|
|
New Frontiers in CVD Risk Management
Supporting Early Aggressive Therapy
|
|
| Release Date: 03/20/2006 |
|
Vascular Biology in Clinical Practice © Vol. 7, No. 1
|
|
ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection
|
|
| Release Date: 12/06/2005 |
|
Vascular Biology in Clinical Practice © Vol. 6, No. 3
|
|
A HOPE FOR PEACE?
Update on the role of ACE inhibition
in CAD patients
|
|
| Release Date: 01/24/2005 |
|
Vascular Biology in Clinical Practice © Vol. 6, No. 2
|
|
High-dose statins and early benefit in ACS: Role of inflammation
|
|
| Release Date: 12/09/2004 |
|
Vascular Biology in Clinical Practice © Vol. 6, No. 1
|
|
How low should LDL-C level be? New data, new direction
|
|
| Release Date: 10/13/2004 |
|
Vascular Biology in Clinical Practice © Vol. 5, No. 3
|
|
Atrial fibrillation and thromboembolism: Implications for stroke prevention
|
|
| Release Date: 12/31/2003 |
|
Vascular Biology in Clinical Practice © Vol. 5, No. 2
|
|
Managing lipids in patients with diabetes: New evidence from vascular biology and clinical trials
|
|
| Release Date: 12/29/2003 |
|
Vascular Biology in Clinical Practice © Vol. 5, No. 1
|
|
New strategies for global risk reduction: Focus on lipids and blood pressure
|
|
| Release Date: 09/05/2003 |
|
Vascular Biology in Clinical Practice © Vol. 4, No. 6
|
|
Prevention of stroke and cognitive dysfunction
|
|
| Release Date: 04/03/2003 |
|
Vascular Biology in Clinical Practice © Vol. 4, No. 5
|
|
The potential role of beta-blockade in blunting the progression of atherosclerosis
|
|
| Release Date: 03/27/2003 |
|
Vascular Biology in Clinical Practice © Vol. 4, No. 4
|
|
Anticoagulant therapy in the PCI patient
|
|
| Release Date: 03/04/2003 |
|
Vascular Biology in Clinical Practice © Vol. 4, No. 3
|
|
Peri-interventional care: Rationale for ACE manipulation
|
|
| Release Date: 01/14/2003 |
|
Vascular Biology in Clinical Practice © Vol. 4, No. 2
|
|
Beta-blocker therapy in heart failure: The new vascular biology imperative to blunt progression
|
|
| Release Date: 09/18/2002 |
|
Vascular Biology in Clinical Practice © Vol. 4, No. 1
|
|
LDL at the vascular wall: New insights, new relevance
|
|
| Release Date: 08/28/2002 |
|
Vascular Biology in Clinical Practice © Vol. 3, No. 3
|
|
Lipids in the post-intervention continuum of care: New challenges and strategies in risk management
|
|
| Release Date: 12/01/2001 |
|
Supplement to The American Journal of Cardiology October 18, 2001 vol. 88 (8A)
|
|
A Symposium: Interventions in cardiology: Focus on lipid management in acute and long-term settings
|
|
| Release Date: 10/30/2001 |
|
Vascular Biology in Clinical Practice © Vol. 3, No. 2
|
|
New insights into the antiatherosclerotic potential of ACE inhibition
|
|
| Release Date: 09/10/2001 |
|
Vascular Biology in Clinical Practice © Vol. 3, No. 1
|
|
Cardiovascular risk reduction in the diabetic patient
|
|
| Release Date: 06/12/2001 |
|
Vascular Biology in Clinical Practice © Vol. 2, No. 3
|
|
Diabetes and cardiovascular disease: The emerging role of the endothelium and implications for treatment
|
|
| Release Date: 02/28/2001 |
|
Vascular Biology in Clinical Practice © Vol. 2, No. 2
|
|
RAS, lipids, and inflammation: New insights for therapeutic intervention
|
|
| Release Date: 02/01/2001 |
|
Vascular Biology in Clinical Practice © Vol. 2, No. 1
|
|
Bradykinin and angiotensin-(1-7): Emerging allies in vascular functioning
|
|
| Release Date: 10/10/2000 |
|
Vascular Biology in Clinical Practice © Vol. 1, No. 4
|
|
Clinical trials update: Tissue ACE inhibition offers new hope for treating cardiovascular disease
|
|
| Release Date: 04/15/2000 |
|
Data and Commentary:The HOPE Study
|
|
Effects of angiotensin-converting enzyme inhibition on cardiovascular events in high-risk patients
|
|
| Release Date: 04/01/2000 |
|
Data and Commentary: The BANFF Study
|
|
Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease
|
|
| Release Date: 04/01/2000 |
|
Vascular Biology in Clinical Practice
|
|
The vascular endothelium and CAD: New target considerations in treating the cardiovascular dysmetabolic syndrome
|
|
| Release Date: 11/03/1999 |
|
Vascular Biology in Clinical Practice © Vol. 1, No. 3
|
|
From hypertension to LVH and heart failure
|
|
| Release Date: 11/01/1999 |
|
Vascular Biology in Clinical Practice © Vol. 1, No. 2
|
|
Overview of clinical trials to improve endothelial function
|
|
| Release Date: 07/06/1999 |
|
Vascular Biology in Clinical Practice © Vol. 1, No. 1
|
|
The endothelium: Redefining the origins of cardiovascular disease
|
|
| Release Date: 04/01/1999 |
|
 |
Video Round Table
These slides accompany the Video Round Table, available for download on the VBWG home page.
|
|
Macro- and Microvascular Effects of Hyperglycemia: Addressing Issues and Controversies
|
|
| Release Date: 10/05/2009 |
|
2009 Core Curriculum
|
|
Atrial Fibrillation Mechanisms and Management: Integrating Care for Better Outcomes
|
|
| Release Date: 05/26/2009 |
|
2009 Core Curriculum
|
|
Evidence-Based Recommendations in Hyperglycemia and ACS
|
|
| Release Date: 03/25/2009 |
|
2008 Core Curriculum
|
|
Tailoring Treatment to Risk in Antiplatelet Therapy
|
|
| Release Date: 12/08/2008 |
|
2008 Core Curriculum
|
|
A Team Approach to Reducing Cardiometabolic Risk and Hyperglycemia in ACS: Blueprint for Success
|
|
| Release Date: 11/21/2008 |
|
2008 Core Curriculum
|
|
Progress and Promise in RAAS Blockade
|
|
| Release Date: 03/06/2008 |
|
2008 Core Curriculum
|
|
Leading the Way in Cardiovascular Regenerative Medicine
|
|
| Release Date: 02/13/2008 |
|
2008 Core Curriculum
|
|
Vascular Dysfunction: Sequelae of Acute Hypertension
|
|
| Release Date: 01/24/2008 |
|
2007 Core Curriculum
|
|
Myocardial Ischemia Redefined: Optimal Care in CAD
|
|
| Release Date: 10/09/2007 |
|
2007 Core Curriculum
|
|
Hyperglycemia and Acute Coronary Syndromes
|
|
| Release Date: 06/18/2007 |
|
2007 Core Curriculum
|
|
Contemporary Management of Cardiometabolic Risk
|
|
| Release Date: 05/15/2007 |
|
2006 Core Curriculum
|
|
Advancing Our Understanding of RAAS Modulation in High-Risk Patients
|
|
| Release Date: 12/11/2006 |
|
2006 Core Curriculum
|
|
Targeting Insulin Resistance for Vascular Protection
|
|
| Release Date: 07/31/2006 |
|
2006 Core Curriculum
|
|
Contemporary Management of Myocardial Ischemia
|
|
| Release Date: 05/17/2006 |
|
2006 Core Curriculum
|
|
Antiplatelet Interventions in ACS
|
|
| Release Date: 03/10/2006 |
|
2006 Core Curriculum
|
|
New Frontiers in CVD Risk Management: Optimizing Outcomes in Patients with Multiple Cardiovascular Risks
|
|
| Release Date: 02/01/2006 |
|
2005 Core Curriculum
|
|
Insulin Resistance and Cardiovascular Disease:
New Perspectives From Vascular Biology
|
|
| Release Date: 11/21/2005 |
|
2005 Core Curriculum
|
|
The Renin-Angiotensin-Aldosterone System: Linking New Data and Mechanisms for Cardiovascular Risk Reduction
|
|
| Release Date: 09/30/2005 |
|
2005 Core Curriculum
|
|
Improving Outcomes in Heart Failure: New Insights From Vascular Biology
|
|
| Release Date: 06/09/2005 |
|
2005 Core Curriculum
|
|
RAAS Modulation: Novel Strategies for Reducing Cardiovascular Risk
|
|
| Release Date: 06/09/2005 |
|
Predictor of CV Events and Mortality in Postmenopausal Women: Leukocyte Count
|
|
| Release Date: 03/24/2005 |
|
TNT: New data on intensive lipid lowering in stable CAD patients
|
|
| Release Date: 03/14/2005 |
|
2004 Core Curriculum
|
|
Impact of vascular biology on cardiovascular disease, risk prevention, and treatment
Section IV - Update: RAAS manipulation and
cardiovascular risk--Hope for Peace?
|
|
| Release Date: 01/20/2005 |
|
2004 Core Curriculum
|
|
Impact of vascular biology on cardiovascular
disease, risk prevention, and treatment
Section V: Multiple risk and CV disease prevention
|
|
| Release Date: 09/29/2004 |
|
2004 Core Curriculum
|
|
Impact of vascular biology on cardiovascular disease, risk prevention, and treatment
Section IV: RAAS manipulation and cardiovascular risk
|
|
| Release Date: 08/27/2004 |
|
2004 Core Curriculum
|
|
Impact of vascular biology on cardiovascular disease, risk prevention, and treatment
Section III: Heart failure: The new vascular biology imperative to blunt progression
|
|
| Release Date: 05/06/2004 |
|
2004 Core Curriculum
|
|
Impact of vascular biology on cardiovascular
disease, risk prevention, and treatment
Section II: Blunting the atherosclerotic process: The case for aggressive lipid management
|
|
| Release Date: 04/17/2004 |
|
2004 Core Curriculum
|
|
Impact of vascular biology on cardiovascular disease, risk prevention, and treatment
Section I: Atrial fibrillation, anticoagulation, and stroke prevention
|
|
| Release Date: 04/16/2004 |
|
2003 Core Curriculum
|
|
Impact of vascular biology in treatment of cardiovascular disease
Section V: Atrial fibrillation, anticoagulation, and stroke prevention
|
|
| Release Date: 12/31/2003 |
|
2003 Core Curriculum
|
|
Impact of vascular biology in treatment of cardiovascular disease
Section IV: Antithrombotic interventions in acute coronary syndromes
|
|
| Release Date: 05/28/2003 |
|
2003 Core Curriculum
|
|
Impact of vascular biology in treatment of cardiovascular disease
Section III: Neurohormonal strategies in the failing heart
|
|
| Release Date: 05/03/2003 |
|
2003 Core Curriculum
|
|
Impact of vascular biology in treatment of cardiovascular disease
Section II: Lipid management
|
|
| Release Date: 05/02/2003 |
|
2003 Core Curriculum
|
|
Impact of vascular biology in treatment of cardiovascular disease
Section I: RAAS manipulation
|
|
| Release Date: 05/01/2003 |
|
Cardiovascular considerations in treating erectile dysfunction
|
|
Impact of vascular biology in treatment
of cardiovascular disease
|
|
| Release Date: 04/01/2003 |
|
2002 Core Curriculum
|
|
Impact of vascular biology in treatment of cardiovascular disease
Section IV: Antithrombotic interventions in acute coronary syndromes
|
|
| Release Date: 07/31/2002 |
|
2002 Core Curriculum
|
|
Impact of vascular biology in treatment of cardiovascular disease
Section III: Neurohormonal strategies in heart failure
|
|
| Release Date: 05/13/2002 |
|
2002 Core Curriculum
|
|
Impact of vascular biology in treatment of cardiovascular disease
Section II: Lipid management
|
|
| Release Date: 04/04/2002 |
|
2002 Core Curriculum
|
|
Impact of vascular biology in treatment of cardiovascular disease
Section I: RAS manipulation
|
|
| Release Date: 04/03/2002 |
|
2001 Core Curriculum
|
|
Vascular biology for clinical practice: From basic concepts to mainstream medicine
|
|
| Release Date: 05/03/2001 |
|
2000 Core Curriculum
|
|
The endothelium: New insights into the origins and treatment of CAD
|
|
| Release Date: 08/31/2000 |
|
Postintervention Continuum of Care Update: Ultrasound Assessment of Plaque Dynamics
|
|
Lipids and plaque on ultrasound: New views and new dimensions
|
|
| Release Date: 06/01/2000 |
|
Postintervention Continuum of Care: Focus on Lipids
|
|
| Release Date: 11/01/1999 |
|
The vascular endothelium and CAD: New target considerations in treating the cardiovascular dysmetabolic syndrome
|
|
| Release Date: 09/24/1999 |
|
1999 Core Curriculum
|
|
Endothelial function: Changing the pattern of treating CV disease
|
|
| Release Date: 01/01/1999 |
|
Focus: Lipids and the Endothelium
|
|
The Endothelium: Impact on CAD treatment strategies
|
|
| Release Date: 04/01/1998 |
|
|
Resources